AIA
IHE icon

Allegis Investment Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Allegis Investment Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-165
Closed -$9K – 533
2015
Q4 		$9K Buy
+165
New +$8.68K 0.01% 697

Other funds holding IHE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
EAMA
EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Allegis Investment Advisors's IHE Position: Q1 2016 in Review

Allegis Investment Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2016, closing a stake of 165 shares — an estimated $9K sold.

Allegis Investment Advisors first reported a position in IHE in Q4 2015 and held it in 1 quarter. The position peaked at $9K in Q4 2015. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2016.

  • Allegis Investment Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 165 iShares US Pharmaceuticals ETF shares in Q1 2016, an estimated $9K.
  • Allegis Investment Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2015 and held it in 1 quarter.
  • Allegis Investment Advisors's iShares US Pharmaceuticals ETF position peaked at $9K in Q4 2015.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2016.

Based on Allegis Investment Advisors's 13F filing for Q1 2016, filed 9 May 2016.